A new study suggests that medications that have transformed the treatment of obesity may also help people drink less alcohol.

A small study confirms observations what users have observed: the medications reduce their cravings for alcohol.

In 2022, when the surge in popularity of the GLP-1 class of weight loss and diabetes drugs really began, stories of surprise ...

“The first thing they see is the loose skin on their abdomen," says R. Brannon Claytor, a Bryn Mawr, Pa.-based plastic ...

Novo Nordisk shares rose Wednesday after fourth-quarter earnings beat Wall Street's estimates, 2025 forecast came in line ...

The drugmaker expects the regulator to remove Wegovy and Ozempic from its shortage list, blocking other companies from ...

The results of the first head-to-head trial of Lilly's dual GLP-1/GIP agonist Zepbound (tirzepatide) and Novo Nordisk's GLP-1 agonist Wegovy (semaglutide ... 25% body weight loss compared to ...

Daniel Mitchell-Jones, co-founder of modelling agency Chapter Management, said: "Yes, things have shifted. In 2020 and 2021, ...

More U.S. adults believe it is a good thing than a bad thing for adults to use weight-loss drugs like Ozempic, Wegovy and other ... run hundreds of dollars each time you fill a prescription.

But that will take political will and time ... "King Kong" of weight loss drugs by US expert Dr Julio Rosenstock after its effect size emerged , compared to the "gorilla" of Wegovy.